REQUEST A DEMO
Total
USD $0.00
Search more companies

Lumex Pharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lumex Pharma S.A.S. Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Lumex Pharma S.A.S. is an enterprise located in Colombia, with the main office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on July 31, 2020. 3 (2025) employees currently work for Lumex Pharma S.A.S.. The latest financial highlights indicate a net sales revenue drop of 26.35% in 2024. There was a total growth of 56.67% in Lumex Pharma S.A.S.’s total assets over the same period. The net profit margin of Lumex Pharma S.A.S. decreased by 14.24% in 2024.

Headquarters
Avenida Carrera 19 118 30 Oficina 511
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Lumex Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Lumex Pharma S.A.S. report to view the information.
Financial Auditors:
Purchase the Lumex Pharma S.A.S. report to view the information.
Incorporation Date:
July 31, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Lumex Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-26.35%
Total operating revenue
-26.35%
Operating profit (EBIT)
200.68%
Net Profit (Loss) for the Period
-85.52%
Total Assets
56.67%
Total Equity
7.15%
Operating Profit Margin (ROS)
54.45%
Net Profit Margin
-14.24%
Return on Equity (ROE)
-42.69%
Quick Ratio
-18.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?